Experimental therapeutics of neurodegenerative disorders: unmet needs.

doi:10.1126/science.282.5391.1072

Back to search

Article

Experimental therapeutics of neurodegenerative disorders: unmet needs.

Science (New York, N.Y.) - 6 Nov 1998

Shoulson I

Abstract excerpt

Viewpoint The experimental therapeutics of neurodegenerative disorders is in its infancy, but neuroprotective strategies are already being applied in healthy persons at high risk of developing disease as well as in patients with manifest illness. Knowledge of etiology and pathogenesis, improved d...

Topics

Alzheimer Disease
Animals
Blood-Brain Barrier
Clinical Trials as Topic
Drug Evaluation, Preclinical
Genetic Predisposition to Disease
Hepatolenticular Degeneration
Humans
Huntington Disease
Neurodegenerative Diseases
Neuroprotective Agents
Parkinson Disease

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.